|

Atovaquone Clinical Trials

2 actively recruiting trials across 1 location

Also known as: 566C80, BW-566C, BW-A566C, Mepron

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Emory University2

Indications

  • Cancer2
  • Platinum-Resistant Ovarian Carcinoma1
  • Ovarian High Grade Serous Adenocarcinoma1
  • Diffuse Midline Glioma, H3 K27M-Mutant1
  • Diffuse Intrinsic Pontine Glioma1

Atlanta, Georgia2 trials

Atovaquone Combined With Radiation in Children With Malignant Brain Tumors

Arthur M Blank Hospital

Phase 1
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

Emory University Hospital/Winship Cancer Institute

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.